Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Inhalation Sciences Sweden

0.31 SEK

+4.67 %

Less than 1K followers

ISAB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+4.67 %
-29.91 %
-39.03 %
-37.20 %
-80.37 %
-80.20 %
-93.59 %
-96.97 %
-96.20 %

Inhalation Sciences Sweden, ISAB, is a research company. The company focuses primarily on the production and development of laboratory instruments. The instruments are used to measure particles in inhaled air and how the composition of the air affects the lungs. The company sells products under various brands, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is headquartered in Huddinge.

Read more
Market cap
12.3M SEK
Turnover
318.1K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27.2.
2026

Annual report '25

11.5.
2026

Interim report Q1'26

All
Press releases
ShowingAll content types
Regulatory press release18 hours ago

Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market

Inhalation Sciences Sweden
Regulatory press release11/4/2025, 7:30 AM

Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations

Inhalation Sciences Sweden
Regulatory press release10/24/2025, 6:30 AM

Inhalation Sciences receives IRS order from leading European university hospital

Inhalation Sciences Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release10/7/2025, 7:00 AM

Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference

Inhalation Sciences Sweden
Press release10/2/2025, 6:30 AM

Inhalation Sciences receives service orders from recurring global pharma customers

Inhalation Sciences Sweden
Press release9/19/2025, 6:30 AM

Inhalation Sciences: University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research

Inhalation Sciences Sweden
Press release9/17/2025, 11:45 AM

Inhalation Sciences launches marketing campaign to increase awareness

Inhalation Sciences Sweden
Press release7/1/2025, 8:00 AM

Inhalation Sciences receives service order from recurring global pharmaceutical customer

Inhalation Sciences Sweden
Regulatory press release5/27/2025, 12:00 PM

Inhalation Sciences AB (publ) releases Annual Report 2024

Inhalation Sciences Sweden
Press release5/27/2025, 6:00 AM

Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO)

Inhalation Sciences Sweden
Press release5/22/2025, 6:30 AM

Inhalation Sciences Signs Strategic Agreement with U.S.-based BioLum Sciences, expanding U.S. Presence & Commercial Reach to Advance In Vitro Respiratory Research

Inhalation Sciences Sweden
Press release5/8/2025, 6:30 AM

Inhalation Sciences receives new IRS orders from returning customers - increased demand in line with regulatory requirements

Inhalation Sciences Sweden
Regulatory press release4/24/2025, 6:00 AM

Inhalation Sciences AB reports positive primary and secondary study results in the FDA-funded study of DissolvIt® and receives approval from the FDA to publish the study results

Inhalation Sciences Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.